Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Monospecies and polymicrobial biofilms differentially regulate the phenotype of genotype-specific oral cancer cells.

Arzmi MH, Cirillo N, Lenzo JC, Catmull DV, O'Brien-Simpson N, Reynolds EC, Dashper S, McCullough M.

Carcinogenesis. 2019 Mar 12;40(1):184-193. doi: 10.1093/carcin/bgy137.

PMID:
30428016
2.

Architectural Effects of Star-Shaped "Structurally Nanoengineered Antimicrobial Peptide Polymers" (SNAPPs) on Their Biological Activity.

Shirbin SJ, Insua I, Holden JA, Lenzo JC, Reynolds EC, O'Brien-Simpson NM, Qiao GG.

Adv Healthc Mater. 2018 Nov;7(21):e1800627. doi: 10.1002/adhm.201800627. Epub 2018 Sep 2.

PMID:
30175464
3.

A therapeutic Porphyromonas gingivalis gingipain vaccine induces neutralising IgG1 antibodies that protect against experimental periodontitis.

O'Brien-Simpson NM, Holden JA, Lenzo JC, Tan Y, Brammar GC, Walsh KA, Singleton W, Orth RKH, Slakeski N, Cross KJ, Darby IB, Becher D, Rowe T, Morelli AB, Hammet A, Nash A, Brown A, Ma B, Vingadassalom D, McCluskey J, Kleanthous H, Reynolds EC.

NPJ Vaccines. 2016 Dec 1;1:16022. doi: 10.1038/npjvaccines.2016.22. eCollection 2016.

4.

Outer Membrane Vesicles Prime and Activate Macrophage Inflammasomes and Cytokine Secretion In Vitro and In Vivo.

Cecil JD, O'Brien-Simpson NM, Lenzo JC, Holden JA, Singleton W, Perez-Gonzalez A, Mansell A, Reynolds EC.

Front Immunol. 2017 Aug 25;8:1017. doi: 10.3389/fimmu.2017.01017. eCollection 2017.

5.

Porphyromonas gulae Activates Unprimed and Gamma Interferon-Primed Macrophages via the Pattern Recognition Receptors Toll-Like Receptor 2 (TLR2), TLR4, and NOD2.

Holden JA, O'Brien-Simpson NM, Lenzo JC, Orth RKH, Mansell A, Reynolds EC.

Infect Immun. 2017 Aug 18;85(9). pii: e00282-17. doi: 10.1128/IAI.00282-17. Print 2017 Sep.

6.

Rapid Chair-Side Test for Detection of Porphyromonas gingivalis.

O'Brien-Simpson NM, Burgess K, Lenzo JC, Brammar GC, Darby IB, Reynolds EC.

J Dent Res. 2017 Jun;96(6):618-625. doi: 10.1177/0022034517691720. Epub 2017 Feb 9.

PMID:
28182517
7.

Combating multidrug-resistant Gram-negative bacteria with structurally nanoengineered antimicrobial peptide polymers.

Lam SJ, O'Brien-Simpson NM, Pantarat N, Sulistio A, Wong EH, Chen YY, Lenzo JC, Holden JA, Blencowe A, Reynolds EC, Qiao GG.

Nat Microbiol. 2016 Sep 12;1(11):16162. doi: 10.1038/nmicrobiol.2016.162.

PMID:
27617798
8.

Unprimed, M1 and M2 Macrophages Differentially Interact with Porphyromonas gingivalis.

Lam RS, O'Brien-Simpson NM, Holden JA, Lenzo JC, Fong SB, Reynolds EC.

PLoS One. 2016 Jul 6;11(7):e0158629. doi: 10.1371/journal.pone.0158629. eCollection 2016.

9.

Porphyromonas gulae Has Virulence and Immunological Characteristics Similar to Those of the Human Periodontal Pathogen Porphyromonas gingivalis.

Lenzo JC, O'Brien-Simpson NM, Orth RK, Mitchell HL, Dashper SG, Reynolds EC.

Infect Immun. 2016 Aug 19;84(9):2575-85. doi: 10.1128/IAI.01500-15. Print 2016 Sep.

10.

Differential Responses of Pattern Recognition Receptors to Outer Membrane Vesicles of Three Periodontal Pathogens.

Cecil JD, O'Brien-Simpson NM, Lenzo JC, Holden JA, Chen YY, Singleton W, Gause KT, Yan Y, Caruso F, Reynolds EC.

PLoS One. 2016 Apr 1;11(4):e0151967. doi: 10.1371/journal.pone.0151967. eCollection 2016.

11.

Determination of Active Phagocytosis of Unopsonized Porphyromonas gingivalis by Macrophages and Neutrophils Using the pH-Sensitive Fluorescent Dye pHrodo.

Lenzo JC, O'Brien-Simpson NM, Cecil J, Holden JA, Reynolds EC.

Infect Immun. 2016 May 24;84(6):1753-1760. doi: 10.1128/IAI.01482-15. Print 2016 Jun.

12.

Tannerella forsythia Outer Membrane Vesicles Are Enriched with Substrates of the Type IX Secretion System and TonB-Dependent Receptors.

Veith PD, Chen YY, Chen D, O'Brien-Simpson NM, Cecil JD, Holden JA, Lenzo JC, Reynolds EC.

J Proteome Res. 2015 Dec 4;14(12):5355-66. doi: 10.1021/acs.jproteome.5b00878. Epub 2015 Nov 5.

PMID:
26510619
13.

GM-CSF and uPA are required for Porphyromonas gingivalis-induced alveolar bone loss in a mouse periodontitis model.

Lam RS, O'Brien-Simpson NM, Hamilton JA, Lenzo JC, Holden JA, Brammar GC, Orth RK, Tan Y, Walsh KA, Fleetwood AJ, Reynolds EC.

Immunol Cell Biol. 2015 Sep;93(8):705-15. doi: 10.1038/icb.2015.25. Epub 2015 Mar 10.

PMID:
25753270
14.

Physicochemical and immunological assessment of engineered pure protein particles with different redox states.

Gause KT, Yan Y, Cui J, O'Brien-Simpson NM, Lenzo JC, Reynolds EC, Caruso F.

ACS Nano. 2015 Mar 24;9(3):2433-44. doi: 10.1021/acsnano.5b00393. Epub 2015 Feb 25.

PMID:
25714702
15.

Macrophage depletion abates Porphyromonas gingivalis-induced alveolar bone resorption in mice.

Lam RS, O'Brien-Simpson NM, Lenzo JC, Holden JA, Brammar GC, Walsh KA, McNaughtan JE, Rowler DK, Van Rooijen N, Reynolds EC.

J Immunol. 2014 Sep 1;193(5):2349-62. doi: 10.4049/jimmunol.1400853. Epub 2014 Jul 28.

16.

The promotion of breast cancer metastasis caused by inhibition of CSF-1R/CSF-1 signaling is blocked by targeting the G-CSF receptor.

Swierczak A, Cook AD, Lenzo JC, Restall CM, Doherty JP, Anderson RL, Hamilton JA.

Cancer Immunol Res. 2014 Aug;2(8):765-76. doi: 10.1158/2326-6066.CIR-13-0190. Epub 2014 Apr 29.

17.

Differential roles of the protein corona in the cellular uptake of nanoporous polymer particles by monocyte and macrophage cell lines.

Yan Y, Gause KT, Kamphuis MM, Ang CS, O'Brien-Simpson NM, Lenzo JC, Reynolds EC, Nice EC, Caruso F.

ACS Nano. 2013 Dec 23;7(12):10960-70. doi: 10.1021/nn404481f. Epub 2013 Nov 20.

PMID:
24256422
18.

Sensitizing and Th2 adjuvant activity of cysteine protease allergens.

Cunningham PT, Elliot CE, Lenzo JC, Jarnicki AG, Larcombe AN, Zosky GR, Holt PG, Thomas WR.

Int Arch Allergy Immunol. 2012;158(4):347-58. doi: 10.1159/000334280. Epub 2012 Apr 3.

PMID:
22472801
19.

Regulation of systemic and local myeloid cell subpopulations by bone marrow cell-derived granulocyte-macrophage colony-stimulating factor in experimental inflammatory arthritis.

Cook AD, Turner AL, Braine EL, Pobjoy J, Lenzo JC, Hamilton JA.

Arthritis Rheum. 2011 Aug;63(8):2340-51. doi: 10.1002/art.30354.

20.

Control of macrophage lineage populations by CSF-1 receptor and GM-CSF in homeostasis and inflammation.

Lenzo JC, Turner AL, Cook AD, Vlahos R, Anderson GP, Reynolds EC, Hamilton JA.

Immunol Cell Biol. 2012 Apr;90(4):429-40. doi: 10.1038/icb.2011.58. Epub 2011 Jul 5.

PMID:
21727904
21.

Urokinase-type plasminogen activator and arthritis progression: contrasting roles in systemic and monoarticular arthritis models.

De Nardo CM, Lenzo JC, Pobjoy J, Hamilton JA, Cook AD.

Arthritis Res Ther. 2010;12(5):R199. doi: 10.1186/ar3171. Epub 2010 Oct 25.

22.

Urokinase-type plasminogen activator and arthritis progression: role in systemic disease with immune complex involvement.

Cook AD, De Nardo CM, Braine EL, Turner AL, Vlahos R, Way KJ, Beckman SK, Lenzo JC, Hamilton JA.

Arthritis Res Ther. 2010;12(2):R37. doi: 10.1186/ar2946. Epub 2010 Mar 2.

23.

Effect of both ultraviolet B irradiation and histamine receptor function on allergic responses to an inhaled antigen.

McGlade JP, Gorman S, Lenzo JC, Tan JW, Watanabe T, Finlay-Jones JJ, Thomas WR, Hart PH.

J Immunol. 2007 Mar 1;178(5):2794-802.

24.

The effect of tissue type-plasminogen activator deletion and associated fibrin(ogen) deposition on macrophage localization in peritoneal inflammation.

Cook AD, Vlahos R, Massa CM, Braine EL, Lenzo JC, Turner AL, Way KJ, Hamilton JA.

Thromb Haemost. 2006 Apr;95(4):659-67.

PMID:
16601837
25.

Downregulation of IgE antibody and allergic responses in the lung by epidermal biolistic microparticle delivery.

Kendall M, Mitchell TJ, Costigan G, Armitage M, Lenzo JC, Thomas JA, von Garnier C, Zosky GR, Turner DJ, Stumbles PA, Sly PD, Holt PG, Thomas WR.

J Allergy Clin Immunol. 2006 Feb;117(2):275-82. Epub 2005 Dec 2.

PMID:
16461127
26.

Type I IFN-beta gene therapy suppresses cardiac CD8+ T-cell infiltration during autoimmune myocarditis.

Bartlett EJ, Lenzo JC, Sivamoorthy S, Mansfield JP, Cull VS, James CM.

Immunol Cell Biol. 2004 Apr;82(2):119-26.

PMID:
15061762
27.

Cytokine expression in murine cytomegalovirus-induced myocarditis: modulation with interferon-alpha therapy.

Lenzo JC, Mansfield JP, Sivamoorthy S, Cull VS, James CM.

Cell Immunol. 2003 May;223(1):77-86.

PMID:
12914761
28.

Synergy of type I interferon-A6 and interferon-B naked DNA immunotherapy for cytomegalovirus infection.

Bartlett EJ, Cull VS, Brekalo NL, Lenzo JC, James CM.

Immunol Cell Biol. 2002 Oct;80(5):425-35.

PMID:
12225378
29.

Characterisation of murine cytomegalovirus myocarditis: cellular infiltration of the heart and virus persistence.

Lenzo JC, Fairweather D, Cull V, Shellam GR, James Lawson CM.

J Mol Cell Cardiol. 2002 Jun;34(6):629-40.

PMID:
12054850
30.

Immunomodulation of murine cytomegalovirus-induced myocarditis in mice treated with lipopolysaccharide and tumor necrosis factor.

Lenzo JC, Fairweather D, Shellam GR, Lawson CM.

Cell Immunol. 2001 Oct 10;213(1):52-61.

PMID:
11747356
31.

Ganciclovir and cidofovir treatment of cytomegalovirus-induced myocarditis in mice.

Lenzo JC, Shellam GR, Lawson CM.

Antimicrob Agents Chemother. 2001 May;45(5):1444-9.

32.

Gamma-glutamylcysteine synthetase activity in human lung epithelial (A549) cells: factors influencing its measurement.

Ray S, Misso NL, Lenzo JC, Robinson C, Thompson PJ.

Free Radic Biol Med. 1999 Dec;27(11-12):1346-56.

PMID:
10641729
33.

Expression and localization of cyclo-oxygenase isoforms in non-small cell lung cancer.

Watkins DN, Lenzo JC, Segal A, Garlepp MJ, Thompson PJ.

Eur Respir J. 1999 Aug;14(2):412-8.

34.

Expression and localization of COX-2 in human airways and cultured airway epithelial cells.

Watkins DN, Peroni DJ, Lenzo JC, Knight DA, Garlepp MJ, Thompson PJ.

Eur Respir J. 1999 May;13(5):999-1007.

35.

The roles of tumour necrosis factor-alpha, interleukin-1 and interleukin-12 in murine cytomegalovirus infection.

Yerkovich ST, Olver SD, Lenzo JC, Peacock CD, Price P.

Immunology. 1997 May;91(1):45-52.

Supplemental Content

Loading ...
Support Center